Trial
NCT02460484
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
James Baumgartner, MD
Collaborators
Cord Blood Registry, Inc.
Condition
Perinatal Arterial Ischemic Stroke
Intervention
Autologous Cord Blood Infusion
Why stopped
The FDA required a clinical hold for the IND which remained until it was determined that the study would be closed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-16